Course Preview




Disciplines:
  • Nursing
  • Advanced Practice Nursing
Hours: 2 Contact Hours (2 Pharm Hours)
Author(s): Judith Quaranta, PhD, RN, CPN, AE-C, FNAP
Peer Reviewer(s): Karen L. Meyerson, MSN, RN, FNP-C, AE-C
Item#: N1858
Contents: 1 Course Book (48 pages)
Choose the best WS365 Online Nursing Membership for you:
Basic Membership – Access to 1-15 hour courses
PREMIUM Membership – Access to ALL nursing course

Pharmacologic Management of Asthma


Price $16.95
Item # N1858
High-Level Content
When available, the Online Course format is included with the hard copy, eBook, or audio book formats!

Release Date: January 2, 2018

Expiration Date: January 31, 2021

Although asthma is a lifelong disease with no cure, it can be controlled. This course focuses on general pharmacologic interventions for managing asthma as recommended by National Asthma Education Prevention Program (NAEPP) released the Expert Panel Report 3 (EPR3): Guidelines for the Diagnosis and Management of Asthma – Full Report 2007 (NHBLI, 2007) and the Global Initiative for Asthma (GINA) guidelines (2017), which are considered the “gold standard” for treating and managing asthma.

Asthma medicines are used to prevent and control symptoms, to reduce the frequency and severity of acute attacks, and to reverse acute airflow obstruction. Asthma medicines are grouped into two general classes: quick-relief (rescue) and long-term control. Asthma therapy should match the severity of asthma symptoms. Persons classified as having intermittent asthma who are experiencing mild symptoms and those with exercise-induced asthma should be treated with quick-relief medication on an as-needed basis. Those with persistent symptoms should additionally receive a long-term controller medication or medications (intended to be used daily) for asthma control.

 

This course is an extract of, and should not be taken with, N1787 - Asthma Management in Children and Adults, 2nd Edition.

Course Objectives

  • Describe the role of quick-relief medications in the treatment of asthma and their side effects.
  • Describe long-term control medications in the treatment of asthma and their side effects.
  • Discuss the stepwise approach to medication therapy based on asthma severity levels.
  • Describe the vaccines recommended for persons with asthma.
  • Describe the different techniques for asthma medication administration.

Judith Quaranta, PhD, RN, CPN, AE-C, FNAP, is an Assistant Professor in the Decker School of Nursing, Binghamton University. She received her PhD from the Decker School of Nursing, with her dissertation focusing on asthma management of school nurses. Dr. Quaranta’s research focus is on barriers and facilitators for asthma management. As a Train the Trainer for the American Lung Association’s Open Airways for Schools curriculum, she has worked collaboratively with the Broome County Health Department, the Asthma Coalition of the Southern Tier, United Health Services Hospital, and the local American Lung Association to implement this program in local schools. Through integration of Open Airways into course content, undergraduate nursing students teach the program, allowing for sustainability of Open Airways and providing access to asthma self-management education. Dr. Quaranta has been a pediatric nurse since 1979, received her certification in pediatric nursing in 1995, and earned her asthma educator certification in 2009. In April 2017, she was inducted into the National Academies of Practice of Nursing as a Distinguished Fellow for her work with asthma, with a focus on the interprofessional collaboration.

Dr. Quaranta has received Individual Development Awards from Binghamton University, as well as a Transdisciplinary Area of Excellence Award to further her research in asthma. She has presented at multiple national conferences on the topic of asthma and self-management. Dr. Quaranta has also authored manuscripts for numerous journals including the Journal of School Nursing, Journal of Asthma and Allergy Educators, Online Journal of Rural Nursing, Journal of Family Social Work, and Journal of Interprofessional Care, as well as authored chapters in textbooks on research and community and public health.

Karen L. Meyerson, MSN, RN, FNP-C, AE-C, is Director of Commercial Care Management and is a certified asthma educator. She has supervised a staff of certified asthma educators and licensed medical social workers providing intensive case management services for low-income children and adults with uncontrolled asthma. Ms. Meyerson also serves on the Asthma Network’s Speaker’s Bureau and has lectured extensively on asthma for both professional and lay audiences. In addition, she has served as a national speaker and consultant/mentor for asthma programs and coalitions nationwide. She graduated with her Bachelor of Science in Nursing degree from the University of Wisconsin-Madison and her Master of Science in Nursing degree from Grand Valley State University in Grand Rapids, Michigan. She is also a board-certified nurse practitioner, specializing in asthma and allergies. In addition, she has served on the Michigan Department of Community Health-sponsored Michigan Asthma Advisory Committee, the Michigan Pediatric Asthma Mortality Review Panel, and the Michigan Consortium of Asthma Coalitions Steering Team. Nationally, Ms. Meyerson was elected to the National Asthma Educator Certification Board, where she is Chair of the Board, and has presented at Congressional Briefings on Capitol Hill in Washington, DC, on asthma-related issues.

  • Courses must be completed on or before the expiration date noted in the course description above.
  • You must score 75% or higher on the final exam and complete the course evaluation to pass this course and receive a certificate of completion.
  • Through our review processes, Western Schools ensures that this course content is presented in a balanced, unbiased manner and is free from commercial influence. It is Western Schools’ policy not to accept commercial support.
  • All persons involved in the planning and development of this course have disclosed no relevant financial relationships or other conflicts of interest related to the course content.